Literature DB >> 2926417

Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease.

S E Starkstein1, M Esteguy, M L Berthier, H Garcia, R Leiguarda.   

Abstract

Seven patients with Parkinson's disease and severe motor fluctuations were studied with event-related potentials, reaction and movement times and neuropsychological tests while in "off" and "on" phases. While there was a significant decrement in the P300 latency of the event-related potentials and in the duration of movement time in the "on" phase, no significant differences between on and off phases were observed in reaction time and neuropsychological tasks.

Entities:  

Mesh：

Year:  1989        PMID： 2926417      PMCID： PMC1032407          DOI： 10.1136/jnnp.52.3.338

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  7 in total

1.  Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.

Authors:  R G Brown; C D Marsden; N Quinn; M A Wyke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

2.  On the neural origin of P300 in man.

Authors:  C C Wood; T Allison; W R Goff; P D Williamson; D D Spencer
Journal:  Prog Brain Res       Date:  1980       Impact factor: 2.453

3.  Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events.

Authors:  E Halgren; N K Squires; C L Wilson; J W Rohrbaugh; T L Babb; P H Crandall
Journal:  Science       Date:  1980-11-14       Impact factor: 47.728

4.  Cognition in Parkinson disease: an event-related potential perspective.

Authors:  E C Hansch; K Syndulko; S N Cohen; Z I Goldberg; A R Potvin; W W Tourtellotte
Journal:  Ann Neurol       Date:  1982-06       Impact factor: 10.422

5.  Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease.

Authors:  F Girotti; F Carella; M P Grassi; P Soliveri; R Marano; T Caraceni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154

6.  Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa.

Authors:  F Lhermitte; Y Agid; J L Signoret
Journal:  Arch Neurol       Date:  1978-05

7.  Cognitive concomitants of dopamine system stimulation in parkinsonian patients.

Authors:  E Mohr; G Fabbrini; S Ruggieri; P Fedio; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154
  7 in total
  15 in total

1.  The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Authors:  M Jahanshahi; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Cognitive components of reaction time in Parkinson's disease.

Authors:  N Jordan; H J Sagar; J A Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

3.  Relations between on-off phenomena and cognitive functions in Parkinson disease.

Authors:  G Meco; V Bonifati; L Bedini; A Bellatreccia; N Vanacore; A Franzese
Journal:  Ital J Neurol Sci       Date:  1991-02

Review 4.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 5.  Deterioration of dopaminergic pathways and alterations in cognition and motor functions.

Authors:  B Dubois; B Pillon; Y Agid
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

6.  Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease.

Authors:  A Antal; R Pfeiffer; I Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.

Authors:  S E Starkstein; L Sabe; G Petracca; E Chemerinski; G Kuzis; M Merello; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

8.  Apomorphine induced cognitive changes in Parkinson's disease.

Authors:  E Růzicka; J Roth; N Spacková; P Mecír; R Jech
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

9.  Prolonged P300 latency in children with the D2 dopamine receptor A1 allele.

Authors:  E P Noble; S M Berman; T Z Ozkaragoz; T Ritchie
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

10.  Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation.

Authors:  D Prasher; L Findley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.